<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>PENDING</status><version>v2</version><patient-age/><report-id>US-PFIZER INC-2013030787</report-id><gender>female</gender><reactions><reaction>Headache</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>Xeljanz</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Rheumatoid arthritis</indication></indications><outcomes/><country>United States</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>psur</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4254110_P31</messagenumb>
		<messagesenderidentifier>PFIZERINC</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20130125151548</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>1</safetyreportversion>
		<safetyreportid>US-PFIZER INC-2013030787</safetyreportid>
		<primarysourcecountry>US</primarysourcecountry>
		<occurcountry>US</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2013-01-25</transmissiondate>
		<reporttype>1</reporttype>
		<serious code="2">No</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>2</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>2</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2013-01-22</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2013-01-22</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>2</fulfillexpeditecriteria>
		<companynumb>US-PFIZER INC-2013030787</companynumb>
		<duplicate>1</duplicate>
		<reportduplicate>
			<duplicatenumb>W2013107047</duplicatenumb>
		</reportduplicate>
		<primarysource>
			<reportergivename>Christine</reportergivename>
			<reporterfamilyname>Thai</reporterfamilyname>
			<reporterstreet>19582 Beach Blvd Ste
302</reporterstreet>
			<reportercity>Huntington Beach</reportercity>
			<reporterstate>CA</reporterstate>
			<reporterpostcode>92648</reporterpostcode>
			<reportercountry>US</reportercountry>
			<qualification code="1">Physician</qualification>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>PFIZERINC</senderorganization>
			<senderfamilyname>Head Drug Safety Surveillance</senderfamilyname>
			<senderstreetaddress>150 East 42nd Street</senderstreetaddress>
			<sendercity>New York</sendercity>
			<senderstate>New York</senderstate>
			<senderpostcode>10017</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>2127335544</sendertel>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receivertitle>Mr</receivertitle>
			<receivergivename>Roger</receivergivename>
			<receiverfamilyname>Goetsch</receiverfamilyname>
			<receiverstreetaddress>8201 Corporate Drive, Suite 540</receiverstreetaddress>
			<receivercity>Landover</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20785</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>3019189580</receivertel>
			<receivertelextension>194</receivertelextension>
			<receivertelcountrycode>001</receivertelcountrycode>
			<receiverfax>3019183134</receiverfax>
			<receiverfaxcountrycode>001</receiverfaxcountrycode>
		</receiver>
		<patient>
			<patientinitial>PRIVACY</patientinitial>
			<patientsex code="2">Female</patientsex>
			<reaction>
				<primarysourcereaction>Headache</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Headache</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Headache</reactionmeddrapt>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>Xeljanz</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationnumb>203214</drugauthorizationnumb>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugauthorizationholder>Pfizer, Inc.</drugauthorizationholder>
				<drugstructuredosagenumb>5</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>2</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>5 mg, 2x/day</drugdosagetext>
				<drugdosageform normalized="tablet">Tablet</drugdosageform>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Rheumatoid arthritis</drugindication>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<activesubstance>
					<activesubstancename>TOFACITINIB CITRATE</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Headache</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Headache</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
			</drug>
			<summary>
				<narrativeincludeclinical>This is a spontaneous report from a Pfizer <Semaphore x="2473907" class="Occupation" value="Salesperson" score="1.00" ID="C75553">sales </Semaphore>representative by a <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician</Semaphore>. A female patient (age and <Semaphore x="2441774" class="Race" value="Race" score="1.00" ID="C17049">race </Semaphore>unknown) received <Semaphore x="1281423" class="Medicine - tofacitinib - Frequency" value="two" score="0.49" ID=""><Semaphore x="1281398" class="Medicine - tofacitinib - Dose" value="5 mg" score="0.49" ID=""><Semaphore x="1281449" class="Medicine" value="tofacitinib" score="0.87" ID="228000">tofacitinib </Semaphore>(<Semaphore x="1366829" class="Medicine - Xeljanz - Dose" value="5 mg" score="0.49" ID=""><Semaphore x="1366858" class="Medicine" value="Xeljanz" score="0.49" ID="228006">XELJANZ</Semaphore>) <Semaphore x="5503562503159809" class="Medicine - tofacitinib - Dose" value="5 mg" score="0.49" ID="">5 mg </Semaphore></Semaphore></Semaphore>
     <Semaphore x="5503669877342209" class="Medicine - tofacitinib - Frequency" value="two" score="0.49" ID="">two </Semaphore></Semaphore>times a day on an unknown date for <Semaphore x="2469205" class="Disease or Finding" value="Rheumatoid Arthritis" score="1.00" ID="C2884">rheumatoid arthritis</Semaphore>. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unknown date, the patient experienced <Semaphore x="2008813" class="Disease or Finding" value="Headache" score="1.00" ID="C34661">headache </Semaphore>while on the <Semaphore x="1281449" class="Medicine" value="tofacitinib" score="0.87" ID="228000">tofacitinib</Semaphore>. It was reported "her <Semaphore x="2008813" class="Disease or Finding" value="Headache" score="1.00" ID="C34661">headache </Semaphore>went away when she stopped taking the medication for <Semaphore x="1405075" class="Disease or Finding" value="Aagenaes Syndrome" score="1.00" ID="C35709">a little </Semaphore>while after asking the <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>but it came <Semaphore x="1563494" class="AnatomicStructure" value="Back" score="1.00" ID="C13062">back </Semaphore>once she restarted it". The relevant laboratory data was unknown. On unknown date, the patient had stopped <Semaphore x="1281449" class="Medicine" value="tofacitinib" score="0.87" ID="228000">tofacitinib </Semaphore><Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">therapy</Semaphore>. Therapeutic measures taken in <Semaphore x="1854566" class="Disease or Finding" value="Disease Response" score="1.00" ID="C50995">response </Semaphore>to the reported event was unknown. The patient recovered from the event.</narrativeincludeclinical>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>